Cargando…
Autologous whole-blood or autologous serum acupoint injection therapy for chronic urticaria: A systematic review protocol
BACKGROUND: Chronic urticaria (CU) is a common and easily recurring skin disease in the world. Many trials have shown that autologous whole-blood or autologous serum acupoint injection therapy is effective in treating CU. There is currently no systematic review of this therapy. The program aims to e...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636973/ https://www.ncbi.nlm.nih.gov/pubmed/31232963 http://dx.doi.org/10.1097/MD.0000000000016127 |
_version_ | 1783436152223563776 |
---|---|
author | Zhang, Leixiao Xiao, Xianjun Hui, Ruting Shi, Yunzhou Deng, Yanli Zheng, Hui Zheng, Qianhua Zhou, Siyuan Yao, Junpeng Cao, Wei Liu, Ying Hao, Pingsheng Li, Ying |
author_facet | Zhang, Leixiao Xiao, Xianjun Hui, Ruting Shi, Yunzhou Deng, Yanli Zheng, Hui Zheng, Qianhua Zhou, Siyuan Yao, Junpeng Cao, Wei Liu, Ying Hao, Pingsheng Li, Ying |
author_sort | Zhang, Leixiao |
collection | PubMed |
description | BACKGROUND: Chronic urticaria (CU) is a common and easily recurring skin disease in the world. Many trials have shown that autologous whole-blood or autologous serum acupoint injection therapy is effective in treating CU. There is currently no systematic review of this therapy. The program aims to evaluate the effectiveness and safety of this therapy in patients with CU. METHODS: Literature search will be conducted at Medline, PubMed, Excerpt Medica Database, Springer, Web of Science, Cochrane Library, China National Knowledge Infrastructure, Chinese Scientific Journal Database, and other databases. The search date is until May 2019. We will search for popular terms including CU and this therapy. Import the literature electronically. Duplicate documents will be deleted. The primary outcome is the urticaria activity score or other validated scales. Secondary outcomes included response rate, quality of life scale, recurrence rate, and adverse events. A systematic review and search for a randomized controlled trial of this therapy for CU. Implement the Cochrane RevMan V5.3 bias assessment tool to assess bias assessment risk, data integration risk, meta-analysis risk, and subgroup analysis risk (if conditions are met). The mean difference, standard MD, and binary data will be used to represent continuous results. RESULTS: This study will provide a comprehensive review of the available evidence for the treatment of CU with this therapy. CONCLUSION: This study will provide new evidence for assessing the effectiveness and side effects of this therapy for CU. Since the data is not individualized, there is no need for formal ethical approval. PROSPERO REGISTRATION NUMBER: CRD42019128364. |
format | Online Article Text |
id | pubmed-6636973 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-66369732019-08-01 Autologous whole-blood or autologous serum acupoint injection therapy for chronic urticaria: A systematic review protocol Zhang, Leixiao Xiao, Xianjun Hui, Ruting Shi, Yunzhou Deng, Yanli Zheng, Hui Zheng, Qianhua Zhou, Siyuan Yao, Junpeng Cao, Wei Liu, Ying Hao, Pingsheng Li, Ying Medicine (Baltimore) Research Article BACKGROUND: Chronic urticaria (CU) is a common and easily recurring skin disease in the world. Many trials have shown that autologous whole-blood or autologous serum acupoint injection therapy is effective in treating CU. There is currently no systematic review of this therapy. The program aims to evaluate the effectiveness and safety of this therapy in patients with CU. METHODS: Literature search will be conducted at Medline, PubMed, Excerpt Medica Database, Springer, Web of Science, Cochrane Library, China National Knowledge Infrastructure, Chinese Scientific Journal Database, and other databases. The search date is until May 2019. We will search for popular terms including CU and this therapy. Import the literature electronically. Duplicate documents will be deleted. The primary outcome is the urticaria activity score or other validated scales. Secondary outcomes included response rate, quality of life scale, recurrence rate, and adverse events. A systematic review and search for a randomized controlled trial of this therapy for CU. Implement the Cochrane RevMan V5.3 bias assessment tool to assess bias assessment risk, data integration risk, meta-analysis risk, and subgroup analysis risk (if conditions are met). The mean difference, standard MD, and binary data will be used to represent continuous results. RESULTS: This study will provide a comprehensive review of the available evidence for the treatment of CU with this therapy. CONCLUSION: This study will provide new evidence for assessing the effectiveness and side effects of this therapy for CU. Since the data is not individualized, there is no need for formal ethical approval. PROSPERO REGISTRATION NUMBER: CRD42019128364. Wolters Kluwer Health 2019-06-21 /pmc/articles/PMC6636973/ /pubmed/31232963 http://dx.doi.org/10.1097/MD.0000000000016127 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | Research Article Zhang, Leixiao Xiao, Xianjun Hui, Ruting Shi, Yunzhou Deng, Yanli Zheng, Hui Zheng, Qianhua Zhou, Siyuan Yao, Junpeng Cao, Wei Liu, Ying Hao, Pingsheng Li, Ying Autologous whole-blood or autologous serum acupoint injection therapy for chronic urticaria: A systematic review protocol |
title | Autologous whole-blood or autologous serum acupoint injection therapy for chronic urticaria: A systematic review protocol |
title_full | Autologous whole-blood or autologous serum acupoint injection therapy for chronic urticaria: A systematic review protocol |
title_fullStr | Autologous whole-blood or autologous serum acupoint injection therapy for chronic urticaria: A systematic review protocol |
title_full_unstemmed | Autologous whole-blood or autologous serum acupoint injection therapy for chronic urticaria: A systematic review protocol |
title_short | Autologous whole-blood or autologous serum acupoint injection therapy for chronic urticaria: A systematic review protocol |
title_sort | autologous whole-blood or autologous serum acupoint injection therapy for chronic urticaria: a systematic review protocol |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636973/ https://www.ncbi.nlm.nih.gov/pubmed/31232963 http://dx.doi.org/10.1097/MD.0000000000016127 |
work_keys_str_mv | AT zhangleixiao autologouswholebloodorautologousserumacupointinjectiontherapyforchronicurticariaasystematicreviewprotocol AT xiaoxianjun autologouswholebloodorautologousserumacupointinjectiontherapyforchronicurticariaasystematicreviewprotocol AT huiruting autologouswholebloodorautologousserumacupointinjectiontherapyforchronicurticariaasystematicreviewprotocol AT shiyunzhou autologouswholebloodorautologousserumacupointinjectiontherapyforchronicurticariaasystematicreviewprotocol AT dengyanli autologouswholebloodorautologousserumacupointinjectiontherapyforchronicurticariaasystematicreviewprotocol AT zhenghui autologouswholebloodorautologousserumacupointinjectiontherapyforchronicurticariaasystematicreviewprotocol AT zhengqianhua autologouswholebloodorautologousserumacupointinjectiontherapyforchronicurticariaasystematicreviewprotocol AT zhousiyuan autologouswholebloodorautologousserumacupointinjectiontherapyforchronicurticariaasystematicreviewprotocol AT yaojunpeng autologouswholebloodorautologousserumacupointinjectiontherapyforchronicurticariaasystematicreviewprotocol AT caowei autologouswholebloodorautologousserumacupointinjectiontherapyforchronicurticariaasystematicreviewprotocol AT liuying autologouswholebloodorautologousserumacupointinjectiontherapyforchronicurticariaasystematicreviewprotocol AT haopingsheng autologouswholebloodorautologousserumacupointinjectiontherapyforchronicurticariaasystematicreviewprotocol AT liying autologouswholebloodorautologousserumacupointinjectiontherapyforchronicurticariaasystematicreviewprotocol |